Podiatrist, Primary Podiatric Medicine · Raleigh, NC
NPI
1386616415
Since 2006
Specialty
Podiatrist, Primary Podiatric Medicine
Code 213EP1101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1004 Dresser Ct
Raleigh, NC, 27609
Phone (919) 872-2022
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
2,914 services
Medicare patients, 2024
585
Average age 76
Drug cost, 2024
$16K
1,408 prescriptions
Company payments, 2025
$636
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patrick Dougherty was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 433 times for 66 patients. In total Patrick Dougherty billed 2,914 services in 46 codes, and Medicare paid $136K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 433 | 66 | $0.08 | $36.71 |
| 99213 Office E&M - Established | Office | 327 | 218 | $59.37 | $19K |
| 11721 Nail Procedure | Office | 278 | 131 | $30.41 | $8,455 |
| 11056 Removal or Shaving of Skin Growth | Office | 182 | 82 | $55.27 | $10K |
| 99214 Office E&M - Established | Office | 177 | 146 | $84.67 | $15K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 172 | 61 | $0.74 | $128 |
| 29550 Musculoskeletal | Office | 168 | 55 | $11.26 | $1,892 |
| 99203 Office E&M - New | Office | 152 | 152 | $67.54 | $10K |
| 99204 Office E&M - New | Office | 136 | 136 | $104.89 | $14K |
| 97597 Debridement | Office | 117 | 61 | $70.80 | $8,283 |
| 73630 X-ray - Lower Extremity | Office | 114 | 88 | $23.29 | $2,655 |
| 29540 Musculoskeletal | Office | 76 | 38 | $16.62 | $1,263 |
| 17110 Destruction Skin Lesion | Office | 72 | 67 | $72.07 | $5,189 |
| 11720 Nail Procedure | Office | 60 | 22 | $21.86 | $1,312 |
| 11750 Nail Procedure | Office | 56 | 48 | $105.54 | $5,910 |
By year: 2022 $127K for 2,986 services; 2023 $144K for 2,789 services; 2024 $136K for 2,914 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patrick Dougherty prescribed most often to Medicare patients was Terbinafine Hcl, with 669 prescriptions and refills. In total Patrick Dougherty wrote 1,408 Medicare prescriptions that cost $16K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Terbinafine Hcl Generic | 669 | 705 | 357 | $5,877 |
| Gabapentin Generic | 165 | 178 | 53 | $1,605 |
| Ketoconazole Generic | 135 | 137 | 57 | $3,685 |
| Meloxicam Generic | 119 | 119 | 53 | $402 |
| Cephalexin Generic | 59 | 59 | 52 | $497 |
| Nystatin Generic | 55 | 64 | 29 | $693 |
| Pregabalin Generic | 41 | 43 | 22 | $356 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 29 | 29 | 29 | $265 |
| Diclofenac Sodium Generic | 27 | 27 | 12 | $210 |
| Methylprednisolone Generic | 22 | 22 | 20 | $140 |
| Allopurinol Generic | 16 | 28 | Under 11 | $219 |
Brand drugs: - claims; generic drugs: 1,402 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patrick Dougherty $636 ($636 in general payments such as food, travel and fees) from 12 companies. The largest payer was Abbvie Inc. with $200.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 4 | $200 |
| Organogenesis Inc. ORGO | 2 | $67.71 |
| IBSA Pharma Inc. | 3 | $62.67 |
| Amgen Inc. AMGN | 3 | $56.73 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $42.75 |
| Medtronic, Inc. MDT | 2 | $38.78 |
| Smith+Nephew, Inc. SNN | 2 | $37.65 |
| Averitas Pharma Inc. | 1 | $36.22 |
| Globus Medical, Inc. GMED | 1 | $33.72 |
| DePuy Synthes Sales Inc. JNJ | 1 | $23.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.